Table 1: Sociodemographic and clinical characteristics of patients with onco-hematological disease involved in the study. The diffusion of hematological cancer was scored from 1 to 4 considering 1 as a unique localization in one nodal station or extra-nodal; 2 as two or more localizations from the same side of diaphragm, 3 as localizations from both side of diaphragm and 4 diffuse disease. The toxicity of treatment was scored from 1 (mild) to 5 (death), according to common toxicities criteria (CTC), version 4.0 *data not available

VARIABLES		(N°)	(%)
Marital status	Single	17	27.4
	Married/Living with partner	41	66.1
	Divorced	1	1.6
	Widow	3	4.8
Employment status	Housewife	6	9.7
	Unemployed	5	8.1
	Employed	19	30.6
	Retired	29	46.7
	Student	3	4.8
Education level	Primary school	4	6.5
	Secondary school	24	38.7
	High school	24	38.7
	University degree	8	12.9
	Higher	2	3.2
Outpatient service	Outpatient	62	78,2
Follow-up	First admission	1	1.6
	<6 months	7	11.3
	6-12 months	7	11.3
	>12 months	46	74.2
	NA*	1	1.6
Cancer stage	1	1	1.6
	2	7	11.3
	3	6	9.7
	4	44	71
	NA*	4	6.5
Toxicity of treatments	1	1	1.6
	2	5	8.1
	3	14	22.6
	4	25	40.3
	5	13	21
	NA*	4	6.5
Intent of treatment	Curative	31	50
	maintenance	22	35.5
	Supportive	5	8.1
	NA*	4	6.5
Response to treatment	Complete response	6	9.7
	Partial response	27	43.5
	Progression	3	4.8
	Ongoing evaluation	22	35.5
	NA*	4	6.5
Adherenceat 3 months of follow-up	Yes	54	87.1
	No	1	1.6
	Not evaluated	3	4.8
	NA*	4	6.5